1-3 of 3
Mathieu Ferrari
Close
Sort by
Journal Articles

Anti-CD21 Chimeric Antigen Receptor (CAR)-T Cells for T Cell Acute Lymphoblastic Leukaemia (T-ALL)

Nicola C Maciocia, Amy Burley, Francesco Nannini, Patrycja Wawrzyniecka, Margarida Neves, Thaneswari Karpanasamy, Mathieu Ferrari, Teresa Marafioti, Shimobi Onuoha, Asim Khwaja, Paul M Maciocia, Martin Pule
Journal: Blood
Blood (2021) 138 (Supplement 1): 902.
https://doi.org/10.1182/blood-2021-145725
Published: 2021
Journal Articles

A High Sensitivity aCD22 CAR Combined with aCD19 CAR to Generate Dual Targeting CAR T Cells for the Treatment of r/r B-ALL

Evangelia K Kokalaki, Biao Ma, Mathieu Ferrari, Thomas Grothier, Warren Hazelton, Somayya Manzoor, Eren Costu, Saket Srivastava, Ram Jha, Rosalind Gealy, Lukas Stanczuk, Mathew Robson, Julia Taylor, Mohamed El-Kholy, Vania Baldan, Matteo Righi, James Sillibourne, Shimobi Onuoha, Sara Ghorashian, Shaun P Cordoba, Persis J Amrolia, Martin Pule
Journal: Blood
Blood (2021) 138 (Supplement 1): 1710.
https://doi.org/10.1182/blood-2021-152655
Published: 2021
Journal Articles

Structure Guided Engineering of Highly Specific Chimeric Antigen Receptors for the Treatment of T Cell Lymphomas

Shimobi Onuoha, PhD, Mathieu Ferrari, Anna Bulek, Reyisa Bughda, Somayya Manzoor, Saket Srivastava, Biao Ma, Rajesh Karattil, Alex Kinna, PhD, Patrycja Wawrzyniecka, Simon Thomas, PhD, Shaun P Cordoba, PhD, Paul Maciocia, BSc, MBChB, MRCP, Martin Pule, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1661.
https://doi.org/10.1182/blood-2018-99-119564
Published: 2018